In summary, the mechanism of disease for MDD may be tonic hyperactivity of GluN2D subtypes in MDD-relevant neuronal circuits, and the mechanism of action for uncompetitive NMDAR antagonists for the treatment of MDD may be tonic block of hyperactive GluN2D subtypes. Here, GRIN2D is linked to major depressive disorder.